Bioengineered Protein Drug Market Regional Analysis:
North American Market Insights
The North America industry is estimated to dominate majority revenue share of by 2035. North America is known to have a strong network of drug companies. On the back of the increasing expenditure on healthcare, both by public and private entities, along with the increase in research and developmental activities and the prevalence of chronic diseases amongst individuals in the region, the North American bioengineered protein drug market is anticipated to grow at a rapid pace during the forecast period. For instance, in every 10 people in the United States, one of them has some sort of chronic disease such as diabetes, cancer, or heart disease. North America is known to have a very strong healthcare infrastructure present in the region which is also anticipated to boost the market growth over the forecast period.
APAC Market Insights
The Asia Pacific bioengineered protein drug market, amongst the market in all the other regions, is projected to hold the second largest share during the forecast period. The growth of the market can be attributed majorly to the increasing instances of chronic diseases in the region backed by the boom in the population. Asia continent is known to have the largest population with a remarkable number of geriatrics. For instance, by the year 2050, there will be around 1 billion people aged 65 and above.
Europe Market Insights
The European bioengineered protein drug market, amongst the market in all the other regions, is estimated to grow significantly till 2035. The growth of the market in the region can be accounted for a higher number of people living with diabetes in the region along with the presence of major bioengineered protein drug manufacturers. For instance, in 2022, nearly 20% of the population in the Europe region was anticipated to be aged 65 and above.
